RHUMBLINE ADVISERS - JOUNCE THERAPEUTICS INC ownership

JOUNCE THERAPEUTICS INC's ticker is JNCE and the CUSIP is 481116101. A total of 83 filers reported holding JOUNCE THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.7%.

Quarter-by-quarter ownership
RHUMBLINE ADVISERS ownership history of JOUNCE THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$117
+67.1%
63,356
+0.5%
0.00%
Q4 2022$70
-100.0%
63,066
-0.1%
0.00%
Q3 2022$148,000
-14.9%
63,129
+9.9%
0.00%
Q2 2022$174,000
-40.4%
57,441
+33.5%
0.00%
Q1 2022$292,000
-21.7%
43,035
-3.8%
0.00%
Q4 2021$373,000
+18.0%
44,718
+5.0%
0.00%
Q3 2021$316,000
+12.1%
42,573
+2.8%
0.00%
Q2 2021$282,000
-1.4%
41,406
+48.7%
0.00%
Q1 2021$286,000
+41.6%
27,847
-3.6%
0.00%
Q4 2020$202,000
-1.9%
28,897
+14.4%
0.00%
Q3 2020$206,000
+2.5%
25,262
-13.1%
0.00%
Q2 2020$201,000
+52.3%
29,069
+4.8%
0.00%
Q1 2020$132,000
-40.3%
27,735
+9.6%
0.00%
Q4 2019$221,000
+166.3%
25,305
+1.1%
0.00%
Q3 2019$83,000
-27.2%
25,029
+9.1%
0.00%
Q2 2019$114,000
-5.8%
22,935
+17.1%
0.00%
Q1 2019$121,000
+86.2%
19,590
+2.3%
0.00%
Q4 2018$65,000
-27.0%
19,151
+39.4%
0.00%
Q3 2018$89,000
-21.2%
13,741
-6.8%
0.00%
Q2 2018$113,000
-60.5%
14,741
+15.0%
0.00%
-100.0%
Q1 2018$286,000
+113.4%
12,817
+22.2%
0.00%
Q4 2017$134,00010,4920.00%
Other shareholders
JOUNCE THERAPEUTICS INC shareholders Q4 2017
NameSharesValueWeighting ↓
BML Capital Management, LLC 1,087,961$2,012,7281.74%
Opaleye Management Inc. 2,880,000$5,328,0001.60%
TANG CAPITAL MANAGEMENT LLC 5,300,087$9,805,1611.46%
Ardent Capital Management, Inc. 923,463$1,708,4071.23%
Beryl Capital Management LLC 610,831$1,130,0370.89%
Arena Investors LP 610,639$1,129,6820.88%
Omega Fund Management, LLC 275,513$509,6990.33%
Deep Track Capital, LP 4,259,653$7,880,3580.32%
PenderFund Capital Management Ltd. 246,310$6160.19%
GABELLI & Co INVESTMENT ADVISERS, INC. 425,100$786,4350.15%
View complete list of JOUNCE THERAPEUTICS INC shareholders